To choose the best lead candidates during drug and antibody screening, scientists characterize a molecule’s binding properties, such as kinetics and affinity. Robust assay design reduces experimental ...
Fragment-based drug discovery (FBDD) has gained widespread recognition as a valuable approach in the search for lead drug candidates in drug discovery programs. It is utilized in conjunction with ...
Surface plasmon resonance is a real-time and label-free technique that offers low sample consumption and high throughput when compared to other biophysical techniques and has been widely adopted in ...
Surface plasmon resonance (SPR) is a powerful technique for observing biomolecular interactions due to its ability to quantitatively measure real-time interactions without the need for labels or ...
Real-time, label-free binding analysis is often viewed incorrectly as an ‘art’ instead of a ‘science’. The Octet® SF3 system challenges this notion through user-friendly technology. The field of ...
BOSTON--(BUSINESS WIRE)-- At the SLAS2024 International Conference and Exhibition, Bruker Corporation (Nasdaq: BRKR) today introduced the ground-breaking, new ‘Triceratops’ SPR #64 Surface Plasmon ...
The development of the therapeutic antibodies necessitates a complete understanding of the interaction between the antibody and its target. 1,4 The binding kinetics between the candidate molecule and ...
Surface plasmon resonance (SPR) is not the new kid on the block. It’s been an industry workhorse technology for more than 20 years. What is new is coupling this premier technology with thermodynamic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback